Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm

NCT00682760 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharospasm

Interventions

DRUG: Korean Botulinum toxin type A (KbtxA) and Botox injection

Sponsor

Pacific Pharmaceuticals